Streetbeat News

Analyst Ratings

ARVN

Citigroup analyst Yigal Nochomovitz downgraded Arvinas (NASDAQ:ARVN) from Buy to Neutral but raised the price target from $36 to $55.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:35 pm

ABNB

DA Davidson analyst Tom White downgraded Airbnb (NASDAQ:ABNB) from Buy to Neutral and set a price target of $145.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:32 pm

QDEL

Raymond James analyst Andrew Cooper downgraded QuidelOrtho (NASDAQ:QDEL) from Strong Buy to Outperform and reduced the price target from $100 to $76.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:30 pm

QDEL

William Blair analyst Andrew Brackmann downgraded QuidelOrtho (NASDAQ:QDEL) from Outperform to Market Perform, indicating a change in the firm's outlook on the company.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:27 pm

ULTA

Loop Capital analyst Anthony Chukumba downgrades Ulta Beauty (ULTA) from Buy to Hold and sets a new price target of $530.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:24 pm

CBAY

LifeSci Capital analyst Cory Jubinville downgraded CymaBay Therapeutics (NASDAQ:CBAY) from Outperform to Market Perform, indicating a change in the firm's outlook on the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:21 pm

BL

William Blair analyst Matthew Pfau downgraded BlackLine (NASDAQ:BL) from Outperform to Market Perform, indicating a neutral outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:17 pm

DVA

Truist Securities analyst David Macdonald maintains a Hold rating on DaVita (NYSE:DVA) and raises the price target from $120 to $130.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:15 pm

DINO

UBS analyst Manav Gupta upgrades HF Sinclair (NYSE:DINO) from Neutral to Buy and raises the price target from $64 to $73.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:11 pm

HBAN

UBS analyst Erika Najarian upgrades Huntington Bancshares (NASDAQ:HBAN) from Neutral to Buy and raises the price target from $14 to $15.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:10 pm